Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Feb 14, 2022
- Accession no.
- 0001209191-22-009460
- Filed
- Feb 14, 2022
- Trade date
- Feb 10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $302.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | SSaleDisposed | −14,706 | $15.01 | −$220,737.06 | 8,115,086 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −5,294 | $15.37 | −$81,368.78 | 8,109,792 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.